Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2001-02-15
2002-10-01
Zitomer, Stephanie W. (Department: 1655)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S174000, C435S283100, C435S287200, C435S287500, C435S288500, C422S068100, C422S081000, C436S524000
Reexamination Certificate
active
06458545
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of Invention
This invention relates to a biochip for testing such substances as DNA, RNA or protein; and, more particularly, to a biochip that is safe and reduces cost of testing.
2. Description of the Prior Art
A biochip, such as a DNA chip, comprises several thousand to several hundred thousand types of known DNA segments, also referred to as DNA probes, deposited in a plurality of arrays on a substrate. If a solution containing an unknown DNA segment, also referred to as a DNA target, is caused to flow onto such a DNA chip, DNA segments of the same type combine with each other. This property is utilized so that a DNA probe, wherein such combination has taken place, is examined using a biochip reader, and thus, the sequence of the DNA target, for example, is determined.
FIG. 1
shows an example of hybridization seen in a biochip, wherein six DNA probes DN
01
, DN
02
, DN
03
, DN
04
, DN
05
and DN
06
are deposited in a plurality of arrays on a substrate SB
01
, thus forming a DNA chip. A DNA target UNO
1
is previously marked with a fluorescent marker LM
01
. When hybridized to the DNA chip, the DNA target combines with a DNA probe whose sequence is complementary. For example, the DNA target UNO
1
combines with DNA probe DN
01
, as indicated by CB
01
. Using a biochip reader, excitation light is irradiated at the DNA chip, thus hybridized, in order to detect fluorescent light produced at the fluorescent marker. Hence, it is possible to know which of the DNA probes the DNA target has combined with. For example, in an image SI
01
resulting from scanning a DNA chip, fluorescent light is observed at the spot LD
01
whereat the DNA combination CB
01
was produced.
FIG. 2
shows a DNA chip as the biochip, wherein the biochip comprises a substrate
1
, on which known DNA segments are deposited in a plurality of arrays (referred to as “substrate
1
”); a cartridge
2
wherein the substrate
1
is housed and to which a solution containing a DNA target previously marked with a fluorescent marker is introduced; and an inlet opening
3
formed on cartridge
2
through which a solution is introduced. Cartridge
2
comprises a material which is permeable to both excitation light and fluorescent light produced thereby at the marker. Cells CL
11
, CL
12
, CL
13
, CL
14
, CL
15
and CL
16
, in each of which a plurality of DNA probes of the same type are placed, are deposited in arrays on substrate
1
.
The method of testing DNA or other substance using the biochip of
FIG. 2
is described with reference to
FIGS. 3 and 4
, wherein
FIG. 3
shows an example of introducing solution into cartridge
2
, and
FIG. 4
shows art example of scanning a hybridized DNA chip using a biochip reader to determine the sequence of target DNA, for example.
FIG. 3
shows components
1
to
3
which are the same as those in FIG.
2
.
In a first step, blood is collected using a syringe from a person being tested. A solution that was preprocessed is then introduced through an inlet opening
3
into cartridge
2
. Solution infusion means or device
4
, such as a pipette, is loaded with a preprocessed solution
5
. The tip of solution infusion device
4
is inserted in inlet opening
3
and solution
5
, inside the device
4
, is injected into cartridge
2
. The preprocessing refers to a series of processes wherein lymphocytes are separated from the collected blood, and then DNA is extracted from the separated lymphocytes, and finally, the extracted DNA is marked with a fluorescent marker.
In a second step, substrate
1
is soaked with solution introduced into cartridge
2
to allow a DNA target in the solution to hybridize with DNA probes placed in each cell on substrate
1
.
In a final step, as shown in
FIG. 4
, hybridized substrate
1
is scanned using a biochip reader
50
so that, for example, the sequence of the DNA target is determined.
In
FIG. 4
, components
1
to
3
and cells CL
11
,CL
12
, and CL
13
are similarly denoted as in FIG.
3
. In addition, light emitted from a light source
6
, such as a laser light source, is reflected by a dichroic mirror
7
, as excitation light and focused through an objective lens
8
onto cells on substrate
1
. For example, excitation light is focused onto cell CL
12
in FIG.
4
. Fluorescent light produced at cell CL
12
on substrate
1
becomes parallel light at it travels through objective lens
8
and is projected onto dichroic mirror
7
. The fluorescent light, thus projected, is transmitted through dichroic mirror
7
. The fluorescent light thus transmitted then travels through a filter
9
and is condensed onto an optical detector
11
by a lens
10
.
The spots, whereon excitation light is focused, are scanned by a drive means (not shown). For example, cartridge
2
or biochip reader
50
itself is scanned so that excitation light is irradiated at the remaining cells CL
11
and CL
13
on substrate
1
. Hence, it is possible to determine the sequence of a-DNA target by identifying the position of a cell on substrate
1
where fluorescence takes place.
Recently, however, test samples, such as blood, have been found to be contaminated with a virus, such as HIV. Hence, there is a growing tendency, for safety reasons, to not recycle various medical devices, such as syringes, for cleaning or sterilization. Instead, disposable devices are preferred. In contrast, the method of introducing a solution, such as shown in
FIG. 3
, involves the risk of the human operator or testor becoming infected by a virus, such as HIV, as result of accidental contact with the solution. This risk is due to the transfer of the solution from the solution infusion device
4
, or the like to cartridge
2
.
Another problem is that the cost of testing is substantial since more than one type of medical equipment or device must be disposed of, including syringes, devices and appliances used for preprocessing purposes, solution infusion devices, DNA chips, etc.
SUMMARY OF THE INVENTION
Accordingly, an object of the invention is to overcome the aforementioned and other deficiencies, disadvantages, and problems of the prior art.
Another object is to provide a biochip which is extremely safe and enables great reduction in cost of testing.
The foregoing and other objects are attained in the invention, which encompasses a biochip collection means for retaining collected blood; preprocessing means for deriving a target from the collected blood; and substrate means on which probes are deposited in arrays with the opening thereto being air tight.
REFERENCES:
patent: 6017696 (2000-01-01), Heller et al.
patent: 6218126 (2001-04-01), Yasuda et al.
Wilding et al. “Integrated Cell Isolation and Polymerase Chain Reaction Analysis Using Silicon Microfilter Chambers” Analytical Biochemistry, 1998, 257:95-100.
Forman BJ
Zitomer Stephanie W.
LandOfFree
Biochip does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biochip, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biochip will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2993544